Clough Capital
Clough Capital Clough is a Boston-based investment advisory firm which manages approximately $3.9 billion in assets: $1.7 billion in hedge fund and institutional accounts; $92 million in open-end mutual funds; and $2.1 billion in three closed-end funds (as of February 28, 2011) - Clough Global Allocation (GLV), Clough Global Equity (GLQ), and the Clough Global Opportunities Fund (GLO). The firm uses a global and theme-based approach and invests in securities on a global basis. Clough was founded in 2000 by Chuck Clough and partners James Canty and Eric Brock. These three are the portfolio managers for the Clough Global Allocation Fund.
View Older Stories
-
Form 4 Clough Global Dividend For: Feb 08 Filed by: Clough Capital Partners, L.P.
-
Form 4 Clough Global Equity For: Feb 08 Filed by: Clough Capital Partners, L.P.
-
Form 4 Clough Global Opportunit For: Feb 08 Filed by: Clough Capital Partners, L.P.
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Sanofi (SNY) Acquires Amunix Immuno-Oncology Pipeline with Next-Gen Conditionally Activated Biologics
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 4 Clough Global Opportunit For: Jun 30 Filed by: Clough Capital Partners, L.P.
-
Form 4 Clough Global Equity For: Jun 30 Filed by: Clough Capital Partners, L.P.
-
Form 4 Clough Global Dividend For: Jun 30 Filed by: Clough Capital Partners, L.P.
-
Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 4 Clough Global Dividend For: May 19 Filed by: Clough Capital Partners, L.P.
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form SC 13G Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 4 Clough Global Equity For: Aug 26 Filed by: Clough Capital Partners, L.P.
-
Form 4 Clough Global Opportunit For: Aug 26 Filed by: Clough Capital Partners, L.P.
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form SC 13G Correvio Pharma Corp. Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form SC 13G Correvio Pharma Corp. Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form SC 13G/A CARVANA CO. Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form SC 13G/A Cardiome Pharma Corp Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form SC 13G/A Cardiome Pharma Corp Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form SC 13G CARVANA CO. Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
-
Form SC 13G/A Cardiome Pharma Corp Filed by: CLOUGH CAPITAL PARTNERS L P
-
Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
-
Form SC 13G/A VERACYTE, INC. Filed by: CLOUGH CAPITAL PARTNERS L P